UnitedHealth CEO Andrew Witty said on Thursday that healthcare in the U.S. needs to be "less confusing, less complex and less costly" during the company's first earnings call since the murder of Brian Thompson,

UnitedHealth, the largest health care company in the U.S., made profits of up to 7,700 percent on lifesaving drugs, the Federal Trade ... the CEO of UnitedHealth Group's insurance wing ...

But high medical costs contributed to results that disappointed Wall Street, and the company’s stock fell on the news that it had made less than analysts expected.

UnitedHealth Group Thursday reported $14.4 billion in 2024 profits including $5.5 billion in the ... [+] fourth quarter as its portfolio of health insurance and provider services overcame rising ...

UnitedHealth is putting pressure on the 30-stock index Thursday after the insurance giant reported a rare revenue miss. This is what you need to know.

In its first results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its shares to fall in early morning trading despite quarterly profit beating projections.

UNH stock is finally returning to form after UnitedHealthcare CEO Brian Johnson was gunned down outside an investor meeting in Midtown Manhattan on December 4, leading to a weeklong manhunt that brought light to UnitedHealth’s record of denying health claims and general unpopularity with the public.

First-quarter earnings season kicks off with results from Citigroup, Goldman Sachs, JPMorgan Chase, Wells Fargo, Bank of America, Morgan Stanley, and UnitedHealth Group.

America's largest health care company, UnitedHealth, made profits of more than 5,000 percent on a lifesaving leukemia drug, according to a Federal Trade ... UnitedHealth Group's Optum, CVS ...

U.S. stock indexes drifted lower following a mixed set of earnings reports from Morgan Stanley, UnitedHealth Group and other big companies

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

While "U.S. exceptionalism" has undoubtedly helped drive Wall Street's record-busting returns in recent years, it should not be confused with isolationism. The fourth-quarter U.S. earnings season that gets underway in earnest this week is a reminder that American firms – magnificent as some may be – still operate in